GSK Consumer

GlaxoSmithKline Pharmaceuticals Ltd on Friday reported a 46 per cent increase in consolidated net profit at Rs 194.48 crore in the fourth quarter ended March 31, on the back of higher sales. The company had posted a net profit of Rs 133.43 crore in the corresponding quarter of the previous fiscal, GlaxoSmithKline Pharmaceuticals (GSK Pharma) said in a regulatory filing. Consolidated revenue from operations in the quarter under review stood at Rs 929.8 crore as against Rs 787.45 crore in the year-ago period, it added. Total expenses in the fourth quarter were higher at Rs 691.41 crore as compared to Rs 635.54 crore in the same period a year ago. The board has recommended a dividend of Rs 32 per equity share on the face value of Rs 10 each for the year ended March 31, subject to approval of members at upcoming annual general meeting, the company said. For the fiscal ended March 31, 2024 net profit was at Rs 589.96 crore as compared to Rs 610.69 crore in the preceding year, the compa

Shares in GSK India closed up 0.3% ahead of results on Thursday, where the Nifty Pharma index closed down 0.03% today

In 2018, HUL had announced that GSK Consumer Healthcare will merge with HUL in an all-stock deal

Synergy benefits from GSK Consumer merger, VWash buy give leg up to firm's portfolio

Excluding the GSK business, overall revenue declined 7 per cent in the quarter, Srinivas Phatak, chief financial officer, HUL, said in a virtual press meet

The toothpaste brand from GSK Consumer ditches the old prescriptive advertising routine, as it looks to widen its appeal among young users

The NCLT nod paves the way for the final leg of the merger process, including an announcement of the record date (of the merger) and share allotment

The British multinational adds a fresh extension to its 40-year-old flagship, hopes to leverage the brand's recall to expand its remedial reach

Nestle India gained 4 per cent to Rs 12,397, and surpassed its previous high of Rs 12,266, recorded on August 9

GSK is streamlining its product offering as it prepares to fold its consumer business into a joint venture with Pfizer by the second half of this year

Net sales fell 1.34% to Rs 1,135.6 crore against Rs 1,151 crore a year ago